SKAN Group AG Stock

Equities

SKAN

CH0013396012

Medical Equipment, Supplies & Distribution

Market Closed - Swiss Exchange 11:30:02 2024-05-17 am EDT 5-day change 1st Jan Change
79.1 CHF -2.59% Intraday chart for SKAN Group AG -1.37% -2.10%
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Hours!
Take advantage of the offer
* See conditions on site
Sales 2024 * 386M 425M Sales 2025 * 456M 501M Capitalization 1.78B 1.96B
Net income 2024 * 39M 42.88M Net income 2025 * 51M 56.08M EV / Sales 2024 * 4.33 x
Net cash position 2024 * 105M 115M Net cash position 2025 * 127M 140M EV / Sales 2025 * 3.62 x
P/E ratio 2024 *
45.2 x
P/E ratio 2025 *
34.7 x
Employees 1,428
Yield 2024 *
0.7%
Yield 2025 *
0.88%
Free-Float 47.23%
More Fundamentals * Assessed data
Dynamic Chart
1 day-2.59%
1 week-1.37%
Current month-3.30%
1 month+1.41%
3 months-2.35%
6 months+6.60%
Current year-2.10%
More quotes
1 week
79.00
Extreme 79
82.80
1 month
76.80
Extreme 76.8
84.00
Current year
72.90
Extreme 72.9
85.40
1 year
65.00
Extreme 65
88.60
3 years
33.00
Extreme 33
95.19
5 years
8.80
Extreme 8.8
95.19
10 years
5.50
Extreme 5.5
95.19
More quotes
Managers TitleAgeSince
Chief Executive Officer 58 08-12-31
Director of Finance/CFO 42 17-12-31
Chief Tech/Sci/R&D Officer 58 22-03-31
Members of the board TitleAgeSince
Chairman 62 21-10-03
Director/Board Member 47 21-10-03
Chief Executive Officer 58 08-12-31
More insiders
Date Price Change Volume
24-05-17 79.1 -2.59% 12,991
24-05-16 81.2 -0.85% 16,947
24-05-15 81.9 +2.12% 17,222
24-05-14 80.2 -0.12% 32,392
24-05-13 80.3 +0.12% 17,389

Delayed Quote Swiss Exchange, May 17, 2024 at 11:30 am EDT

More quotes
SKAN Group AG, former BV Holding AG, is a Switzerland-based holding company of an equity investment group, engaged in the participation in enterprises in Switzerland. It concentrates on companies from the industry, micro and medical technology, processing and material technology, information technology and related services. Target enterprises are those being in special situations, such as management buy-out and buy-in, changes in shareholders’ structure, succession financing, as well as coming through growth or expansion phase. The Company acts as an entrepreneurial partner in the long term. Operational activities are delegated to the independent advisor BV Partners AG. BV Holding AG and BV Partners AG form the BVgroup. As of December 31, 2011, its investment portfolio included nine companies: Covalys BioSciences AG, E2E Technologies Ltd., Lonstroff Holding AG, Piexon AG, POLYDATA AG, SKAN Holding AG, Sphinx Werkzeuge AG, Ypsomed Holding AG and Ziemer Group AG.
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
79.1 CHF
Average target price
95.67 CHF
Spread / Average Target
+20.94%
Consensus

Annual profits - Rate of surprise

-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW